PF-Atlas › Clinical Trials › NCT02004704

A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

GZ402665 · Phase 2

Registry ID

NCT02004704

Phase

Phase 2

Status

Completed

Drug / intervention

GZ402665

Sponsor

Genzyme, a Sanofi Company

Start

2013-12-04

About this trial

GZ402665 is evaluated in NCT02004704, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Genzyme, a Sanofi Company. Current status: Completed.

View NCT02004704 on ClinicalTrials.gov →

Explore related

All GZ402665 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02004704 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.